Compare Eli Lilly And Co (LLY) vs Raytheon Technologies Corp (RTX) Price & Performance

Eli Lilly And CoTrade

Raytheon Technologies CorpTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Raytheon Technologies Corp — how do they compare? Eli Lilly And Co trades at $1,173.2 (market cap $1.02T), while Raytheon Technologies Corp trades at $193.75 (market cap $261.85B). The key difference: Eli Lilly And Co is far larger — about 3.9× Raytheon Technologies Corp's market cap, and Raytheon Technologies Corp pays the higher dividend (1.5%). Which is the better fit depends on your goals.

	LLY	RTX
Market Cap	$1.02T	$261.85B
Sector	Health	Industrials
52-Week High	$1.24K	$212.16
52-Week Low	$625.65	$149.17
Enterprise Value	$1.06T	$293.97B
Dividend Yield	0.6%	1.5%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eli Lilly And Co

No Aura AI signal available yet.

Raytheon Technologies Corp

RTX trades at $193.51, down 0.44% today, with a bullish technical signal and strong analyst support. Recent contract wins, including a $515 million Navy radar deal (PRNewsWire, June 3, 2026), and earnings beats in Q4 2025 and Q1 2026 highlight operational momentum. Revenue growth accelerated to $88.6 billion in 2025, with net income margin improving to 8.03%. The stock faces resistance near $196-$199, with support at $192.

The outlook remains positive given defense spending tailwinds and production expansions, but elevated P/E of 36.48 poses valuation risk. Analysts project 10% upside to a $213 consensus target, with no sell ratings. Key risks include debt levels and geopolitical volatility affecting contracts.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LLY

Over 180 companies develop 200+ PD-1/PD-L1 inhibitors, reshaping cancer treatment landscape.Delveinsight · 5 hours agoBullish Novo Nordisk sues Eli Lilly over misleading GLP-1 drug ads claiming superior weight-loss results.Proactive Investors · 10 hours agoBearish Novo Nordisk sues Eli Lilly over misleading ads on obesity and diabetes drug efficacy.CNBC · 14 hours agoBearish View details →

RTX

OpenAI and Anthropic boost lobbying to $3.17M in Q2 ahead of IPOs and midtermsCNBC · 9 hours agoNeutral Collins Aerospace and Etihad Engineering form JV to expand aircraft MRO services in Abu Dhabi.PRNewsWire · 10 hours agoBullish Tigerair Taiwan orders 15 Airbus A321neos with fuel-efficient Pratt & Whitney GTF engines.PRNewsWire · 11 hours agoBullish View details →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

About Raytheon Technologies Corp

Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.